• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEW
    Legal
    Terms of usePrivacy policyCookie policy

    High Tide Closes on $30 Million Convertible Debt from Cronos Group Inc.

    7/16/25 4:01:00 PM ET
    $CRON
    $HITI
    Medicinal Chemicals and Botanical Products
    Health Care
    Other Specialty Stores
    Consumer Discretionary
    Get the next $CRON alert in real time by email

    CALGARY, AB, and TORONTO, ON, July 16, 2025 /PRNewswire/ - High Tide Inc. ("High Tide") (NASDAQ:HITI) (TSXV:HITI) (FSE: 2LYA), the high-impact, retail-forward enterprise built to deliver real-world value across every component of cannabis, announced today that it has closed a loan agreement (the "Loan Agreement") with a wholly owned subsidiary of Cronos Group Inc. (NASDAQ:CRON) (TSX:CRON) to secure convertible debt with a principal amount of $30 million (the "Junior Secured Loan").

    High Tide Inc., July 16, 2025 (CNW Group/High Tide Inc.)

    High Tide intends to use this working capital to fund future acquisitions and organic growth as it seeks to expand its business and grow its domestic store network beyond 300 locations in Canada.

    "Given our strong and proven business model, it's incredibly validating to receive a second vote of confidence in the form of an investment from a major licensed producer in recent months," said Raj Grover, Founder and Chief Executive Officer of High Tide. "Their support speaks volumes about the value High Tide brings to the legal cannabis ecosystem, not only as a growth-focused retailer but as a key industry player that's helping improve the operating environment for licensed producers, reduce illicit market share, and reinforce Canada's regulated framework overall. With this investment, which will serve entirely as growth capital, we're poised to accelerate our expansion both in Canada and internationally."

    "Our investment was driven by the belief that a competitive and equitable retail environment benefits the entire industry, including producers, retailers and adult consumers," said Mike Gorenstein, Chairman, President and Chief Executive Officer of Cronos. "We remain fully committed to working with and supporting all our retail partners."

    Transaction Details

    The Junior Secured Loan is secured by a third priority lien on certain of High Tide's assets and bears interest at 4% per annum. Pursuant to the terms of the Loan Agreement, Cronos may, with the agreement of High Tide, from time to time, convert the Junior Secured Loan, excluding the amounts attributed to the original issuance discount, into common shares in the capital of High Tide (the "Common Shares") at a price of $4.20 per Common Share (the Common Shares issued from such conversions, the "Conversion Shares"). The Junior Secured Loan has a 5-year term and may be repaid, in whole or in part, at any time, at High Tide's option with no penalty.

    Additionally, Cronos received a Common Share purchase warrant (the "Warrant"). The Warrant is exercisable into up to 3,836,317 Common Shares (the "Warrant Shares") at an exercise price of $3.91 per Warrant Share, representing a 25% premium to the 30-day volume weighted average price of High Tide shares on the TSX Venture Exchange (the "TSXV") ending on the trading day prior to the date of this news release, for a period of five years, at Cronos' option.

    The TSXV has conditionally approved the listing of the Conversion Shares and Warrant Shares, subject to the fulfillment of the requirements of the TSXV's conditional approval.

    ABOUT HIGH TIDE

    High Tide, Inc. is the leading community-grown, retail-forward cannabis enterprise engineered to unleash the full value of the world's most powerful plant and is the second-largest cannabis retailer globally by store count1. High Tide (HITI) is uniquely built around the cannabis consumer, with wholly-diversified and fully-integrated operations across all components of cannabis, including:

    Bricks & Mortar Retail: Canna Cabana™ is the largest cannabis retail chain in Canada, with 202 current locations spanning British Columbia, Alberta, Saskatchewan, Manitoba, Ontario and growing. In 2021, Canna Cabana became the first cannabis discount club retailer in the world.

    Retail Innovation: Fastendr™ is a unique and fully automated technology that employs retail kiosks to facilitate a better buying experience through browsing, ordering and pickup.

    Consumption Accessories: High Tide operates a suite of leading accessory e-commerce platforms across the world, including Grasscity.com, Smokecartel.com, Dailyhighclub.com, and Dankstop.com.

    Brands: High Tide's industry-leading and consumer-facing brand roster includes Queen of Bud™, Cabana Cannabis Co™, Daily High Club™, Vodka Glass™, Puff Puff Pass™, Dopezilla™, Atomik™, Hue™, Evolution™ and more.

    CBD: High Tide continues to cultivate the possibilities of consumer CBD through Nuleafnaturals.com, FABCBD.com, blessedcbd.de and blessedcbd.co.uk.

    Wholesale Distribution: High Tide keeps that cannabis category stocked with wholesale solutions via Valiant™.

    Licensing: High Tide continues to push cannabis culture forward through fresh partnerships and license agreements under the Famous Brandz™ name.

    High Tide consistently moves ahead of the currents, having been named one of Canada's Top Growing Companies by the Globe and Mail's Report on Business in 2024 for the fourth consecutive year and was recognized as a top 50 company by the TSX Venture Exchange in 2022, 2024 and 2025. High Tide was also ranked number one in the retail category on the Financial Times list of Americas' Fastest Growing Companies for 2023. To discover the full impact of High Tide, visit www.hightideinc.com. For investment performance, don't miss the High Tide profile pages on SEDAR+ and EDGAR.

    __________

    1 As reported by ATB Capital Markets based on store counts as of February 6, 2025

    Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSXV) accepts responsibility for the adequacy or accuracy of this release.

    CONTACT INFORMATION

    Media Inquiries

    Carter Brownlee

    Communications and Public Affairs Advisor

    High Tide Inc.

    [email protected]

    403-770-3080

    Investor Inquiries

    Vahan Ajamian

    Capital Markets Advisor

    High Tide Inc.

    [email protected]

    ABOUT CRONOS

    Cronos is an innovative global cannabinoid company committed to building disruptive intellectual property by advancing cannabis research, technology and product development. With a passion to responsibly elevate the consumer experience, Cronos is building an iconic brand portfolio. Cronos' diverse international brand portfolio includes Spinach®, PEACE NATURALS® and Lord Jones®. For more information about Cronos and its brands, please visit: thecronosgroup.com.

    Media Inquiries

    Emily Whalen

    [email protected] 

    Investor Inquiries

    Harrison Aaron

    [email protected] 

    CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS

    This press release may contain "forward-looking information" and "forward-looking statements within the meaning of applicable Canadian and U.S. securities legislation and court decisions. All information contained herein that is not clearly historical in nature may constitute forward-looking statements or forward-looking information. The use of any of the words "could", "intend", "expect", "believe", "will", "projected", "estimated" and similar expressions and statements relating to matters that are not historical facts are intended to identify forward-looking information and are based on High Tide's and Cronos' current beliefs or assumptions as to the outcome and timing of such future events. The forward-looking statements herein include, but are not limited to, statements regarding: the aggregate amount of proceeds that High Tide will receive, the satisfaction of conditions precedent, including necessary regulatory approvals including final TSXV approval, High Tide's expected use of proceeds, the listing of the High Tide common shares deliverable on conversion and underlying the High Tide warrants on the TSXV, High Tide's ability to meet its future goals such as reaching 300 stores and the future adult use cannabis retail market in Canada and the anticipated benefits. Readers are cautioned to not place undue reliance on forward-looking information. Actual results and developments may differ materially from those contemplated by these statements. Although High Tide and Cronos believe that the expectations reflected in these statements are reasonable, such statements are based on expectations, factors, and assumptions concerning future events which may prove to be inaccurate and are subject to numerous risks and uncertainties, certain of which are beyond High Tide's and Cronos' control, including but not limited to the risk factors discussed under the heading "Non-Exhaustive List of Risk Factors" in Schedule A to High Tide's current annual information form, risk factors discussed in Cronos' Annual Report on Form 10-K for the year ended December 31, 2024 and its Quarterly Report on Form 10-Q for the quarter ended March 31, 2025, each of which has been filed on SEDAR+ and EDGAR and can be accessed at www.sedarplus.ca and www.sec.gov/edgar, respectively, and elsewhere in this press release, as such factors may be further updated from time to time in High Tide's and or Cronos' periodic filings, available at www.sedarplus.ca and www.sec.gov, which factors are incorporated herein by reference. Forward-looking statements contained in this press release are expressly qualified by this cautionary statement and reflect the High Tide's and Cronos' expectations as of the date hereof and are subject to change thereafter. Neither High Tide nor Cronos  undertake any obligation to update or revise any forward-looking statements, whether as a result of new information, estimates or opinions, future events or results, or otherwise, or to explain any material difference between subsequent actual events and such forward-looking information, except as required by applicable law.

    Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/high-tide-closes-on-30-million-convertible-debt-from-cronos-group-inc-302507067.html

    SOURCE High Tide Inc.

    Get the next $CRON alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $CRON
    $HITI

    CompanyDatePrice TargetRatingAnalyst
    Cronos Group Inc.
    $CRON
    11/2/2022$3.00Mkt Perform
    Bernstein
    Cronos Group Inc.
    $CRON
    7/28/2022Hold → Buy
    Canaccord Genuity
    Cronos Group Inc.
    $CRON
    5/11/2022Neutral → Sector Outperform
    CIBC
    Cronos Group Inc.
    $CRON
    3/22/2022Underweight → Equal Weight
    Barclays
    Cronos Group Inc.
    $CRON
    3/7/2022$4.00 → $3.00Neutral
    Piper Sandler
    Cronos Group Inc.
    $CRON
    2/22/2022$7.00 → $4.25Sell
    Canaccord Genuity
    Cronos Group Inc.
    $CRON
    2/22/2022$7.00 → $4.00Neutral
    Piper Sandler
    High Tide Inc.
    $HITI
    2/22/2022$7.75 → $7.25Neutral
    Cantor Fitzgerald
    More analyst ratings

    $CRON
    $HITI
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Director Rudyk James Daniel

    4 - Cronos Group Inc. (0001656472) (Issuer)

    8/11/25 5:43:32 PM ET
    $CRON
    Medicinal Chemicals and Botanical Products
    Health Care

    SEC Form 4 filed by Director Adler Jason Marc

    4 - Cronos Group Inc. (0001656472) (Issuer)

    8/11/25 5:42:03 PM ET
    $CRON
    Medicinal Chemicals and Botanical Products
    Health Care

    SEC Form 4 filed by Director Garnick Murray R

    4 - Cronos Group Inc. (0001656472) (Issuer)

    8/11/25 5:38:54 PM ET
    $CRON
    Medicinal Chemicals and Botanical Products
    Health Care

    $CRON
    $HITI
    SEC Filings

    View All

    SEC Form 6-K filed by High Tide Inc.

    6-K - High Tide Inc. (0001847409) (Filer)

    8/18/25 9:15:35 AM ET
    $HITI
    Other Specialty Stores
    Consumer Discretionary

    SEC Form 6-K filed by High Tide Inc.

    6-K - High Tide Inc. (0001847409) (Filer)

    8/14/25 8:40:08 AM ET
    $HITI
    Other Specialty Stores
    Consumer Discretionary

    SEC Form EFFECT filed by High Tide Inc.

    EFFECT - High Tide Inc. (0001847409) (Filer)

    8/14/25 12:15:15 AM ET
    $HITI
    Other Specialty Stores
    Consumer Discretionary

    $CRON
    $HITI
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Bernstein initiated coverage on Cronos Group with a new price target

    Bernstein initiated coverage of Cronos Group with a rating of Mkt Perform and set a new price target of $3.00

    11/2/22 6:32:18 AM ET
    $CRON
    Medicinal Chemicals and Botanical Products
    Health Care

    Cronos Group upgraded by Canaccord Genuity

    Canaccord Genuity upgraded Cronos Group from Hold to Buy

    7/28/22 9:01:16 AM ET
    $CRON
    Medicinal Chemicals and Botanical Products
    Health Care

    Cronos Group upgraded by CIBC

    CIBC upgraded Cronos Group from Neutral to Sector Outperform

    5/11/22 7:33:42 AM ET
    $CRON
    Medicinal Chemicals and Botanical Products
    Health Care

    $CRON
    $HITI
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    High Tide Announces Preliminary Q3 2025 Guidance

    The Company Expects Record Revenue, Adjusted EBITDA Ahead of Analyst Forecasts and a Two-Year High in Same-Store Sales Growth The Company Also Shares Details of Its Q3 2025 Earnings Event CALGARY, AB, Aug. 18, 2025 /PRNewswire/ - High Tide Inc. ("High Tide" or the "Company") (NASDAQ:HITI) (TSXV:HITI) (FSE: 2LYA), the high-impact, retail-forward enterprise built to deliver real-world value across every component of cannabis, is pleased to release guidance estimates regarding anticipated results for its third fiscal quarter ended July 31, 2025.  Management Guidance Range (Expres

    8/18/25 8:00:00 AM ET
    $HITI
    Other Specialty Stores
    Consumer Discretionary

    High Tide to Become Major Player in German Medical Cannabis Market Through Acquisition of Majority Stake in Remexian Pharma GmbH

    Remexian Generated €65 Million in Revenue in the Last 12 Months Remexian Sold 7 Tonnes of Cannabis Flower in Q2 2025, Representing 16% of the 43 Tonnes Imported into Germany in the Quarter1 CALGARY, AB, Aug. 14, 2025 /PRNewswire/ - High Tide Inc. ("High Tide" or the "Company") (NASDAQ:HITI) (TSXV:HITI) (FSE: 2LYA), the high-impact, retail-forward enterprise built to deliver real-world value across every component of cannabis, announced today that it is entering the fast growing German medical cannabis market by signing a definitive agreement (the "Acquisition Agreement") pursuant to which the Company will acquire 51% of Remexian Pharma GmbH ("Remexian"), for a preliminary estimated purchase

    8/14/25 8:00:00 AM ET
    $HITI
    Other Specialty Stores
    Consumer Discretionary

    High Tide Provides Corporate Updates

    CALGARY, AB, Aug. 12, 2025 /PRNewswire/ - High Tide Inc. ("High Tide" or the "Company") (NASDAQ:HITI) (TSXV:HITI) (FSE: 2LYA), the high-impact, retail-forward enterprise built to deliver real-world value across every component of cannabis, is pleased to provide several corporate updates. Germany Update High Tide is pleased to share that it continues to make solid progress on the previously disclosed proposed transaction with a leading German medical cannabis importer and wholesaler. This contemplated transaction is already fully funded following the junior secured loan the Com

    8/12/25 6:00:00 AM ET
    $HITI
    Other Specialty Stores
    Consumer Discretionary

    $CRON
    $HITI
    Leadership Updates

    Live Leadership Updates

    View All

    High Tide to Become Major Player in German Medical Cannabis Market Through Acquisition of Majority Stake in Remexian Pharma GmbH

    Remexian Generated €65 Million in Revenue in the Last 12 Months Remexian Sold 7 Tonnes of Cannabis Flower in Q2 2025, Representing 16% of the 43 Tonnes Imported into Germany in the Quarter1 CALGARY, AB, Aug. 14, 2025 /PRNewswire/ - High Tide Inc. ("High Tide" or the "Company") (NASDAQ:HITI) (TSXV:HITI) (FSE: 2LYA), the high-impact, retail-forward enterprise built to deliver real-world value across every component of cannabis, announced today that it is entering the fast growing German medical cannabis market by signing a definitive agreement (the "Acquisition Agreement") pursuant to which the Company will acquire 51% of Remexian Pharma GmbH ("Remexian"), for a preliminary estimated purchase

    8/14/25 8:00:00 AM ET
    $HITI
    Other Specialty Stores
    Consumer Discretionary

    High Tide Provides Corporate Updates

    CALGARY, AB, Aug. 12, 2025 /PRNewswire/ - High Tide Inc. ("High Tide" or the "Company") (NASDAQ:HITI) (TSXV:HITI) (FSE: 2LYA), the high-impact, retail-forward enterprise built to deliver real-world value across every component of cannabis, is pleased to provide several corporate updates. Germany Update High Tide is pleased to share that it continues to make solid progress on the previously disclosed proposed transaction with a leading German medical cannabis importer and wholesaler. This contemplated transaction is already fully funded following the junior secured loan the Com

    8/12/25 6:00:00 AM ET
    $HITI
    Other Specialty Stores
    Consumer Discretionary

    Cronos Group Inc. Announces Results of 2025 Annual Meeting of Shareholders

    TORONTO, June 23, 2025 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ:CRON) (TSX:CRON) ("Cronos" or the "Company") today announced that at its Annual Meeting of Shareholders held on Friday, June 20, 2025 (the "Meeting"), shareholders holding a total of 276,989,452 common shares of the Company voted in person or by proxy, representing 71.87% of the total number of common shares of the Company outstanding. Each of the directors listed as a nominee in the Company's definitive proxy statement dated April 25, 2025 was elected as a director of the Company, with each director receiving in excess of 92.3% of the votes cast in favor of his or her election. The detailed results of the vote for the e

    6/23/25 5:30:00 PM ET
    $CRON
    Medicinal Chemicals and Botanical Products
    Health Care

    $CRON
    $HITI
    Financials

    Live finance-specific insights

    View All

    High Tide Announces Preliminary Q3 2025 Guidance

    The Company Expects Record Revenue, Adjusted EBITDA Ahead of Analyst Forecasts and a Two-Year High in Same-Store Sales Growth The Company Also Shares Details of Its Q3 2025 Earnings Event CALGARY, AB, Aug. 18, 2025 /PRNewswire/ - High Tide Inc. ("High Tide" or the "Company") (NASDAQ:HITI) (TSXV:HITI) (FSE: 2LYA), the high-impact, retail-forward enterprise built to deliver real-world value across every component of cannabis, is pleased to release guidance estimates regarding anticipated results for its third fiscal quarter ended July 31, 2025.  Management Guidance Range (Expres

    8/18/25 8:00:00 AM ET
    $HITI
    Other Specialty Stores
    Consumer Discretionary

    Cronos Group Inc. to Hold 2025 Second Quarter Earnings Conference Call on August 7, 2025

    TORONTO, July 25, 2025 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ:CRON) (TSX:CRON) ("Cronos" or the "Company") will hold its 2025 second quarter earnings conference call on Thursday, August 7, 2025 at 8:30 a.m. ET. Cronos' senior management team will discuss the Company's financial results and will be available for questions from the investment community after prepared remarks. To attend the conference call or webcast, participants should register online at https://ir.thecronosgroup.com/events-presentations. To avoid delays, we encourage participants to dial into the conference call fifteen minutes ahead of the scheduled start time. The webcast of the call will be archived for replay o

    7/25/25 8:00:00 AM ET
    $CRON
    Medicinal Chemicals and Botanical Products
    Health Care

    High Tide Reports Second Fiscal Quarter 2025 Financial Results

     The Company Generates $4.9 Million in Free Cash Flow Daily Same Store Sales Across the Canna Cabana Network Increased by 6.2% Year Over Year The Company Discloses That it is in Exclusive Discussions Related to a Transaction with a Leading German Medical Cannabis Importer and Wholesaler This news release constitutes a "designated news release" for the purposes of the Company's prospectus supplement dated August 31, 2023, to its short form base shelf prospectus dated August 3, 2023. The Company Now Operates 200 Canna Cabana Locations Across Canada and Continues to be the Largest Cannabis Retail Brand in the CountryDuring February and March 2025, Canna Cabana Held a 12% Share of the Cannabis R

    6/16/25 4:00:00 PM ET
    $HITI
    Other Specialty Stores
    Consumer Discretionary

    $CRON
    $HITI
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13D/A filed by Cronos Group Inc. (Amendment)

    SC 13D/A - Cronos Group Inc. (0001656472) (Subject)

    4/25/24 6:39:55 PM ET
    $CRON
    Medicinal Chemicals and Botanical Products
    Health Care

    SEC Form SC 13D/A filed by Cronos Group Inc. (Amendment)

    SC 13D/A - Cronos Group Inc. (0001656472) (Subject)

    12/19/22 8:47:03 AM ET
    $CRON
    Medicinal Chemicals and Botanical Products
    Health Care